Kevin Koch

President, ARRAY BIOPHARMA INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 12, 2026Sold 913 shares at $44.33 of Edgewise Therapeutics, Inc.³
Aug 12, 2026Sold 8,276 shares at $43.66 of Edgewise Therapeutics, Inc.³
Aug 12, 2026Sold 8,782 shares at $43.64 of Edgewise Therapeutics, Inc.³
Aug 12, 2026Exercised options 21,875 shares of Edgewise Therapeutics, Inc.³
Aug 12, 2026Exercised options 17,969 shares of Edgewise Therapeutics, Inc.³
Aug 12, 2025Sold 7,972 shares at $13.39 of Edgewise Therapeutics, Inc.⁴
Aug 12, 2025Exercised options 17,968 shares of Edgewise Therapeutics, Inc.⁴
May 2, 2025Sold 4,276 shares at $16.45 of Edgewise Therapeutics, Inc.⁵
May 1, 2025Exercised options 10,417 shares of Edgewise Therapeutics, Inc.⁵
Mar 7, 2025Sold 100 shares at $30.00 of Edgewise Therapeutics, Inc.⁶
Mar 7, 2025Exercised options 100 shares at $0.18 of Edgewise Therapeutics, Inc.⁶
Feb 6, 2025Sold 900 shares at $31.13 of Edgewise Therapeutics, Inc.⁷
Feb 6, 2025Exercised options 900 shares at $13.11 of Edgewise Therapeutics, Inc.⁷
Feb 5, 2025Sold 8,636 shares at $30.03 of Edgewise Therapeutics, Inc.⁷
Feb 5, 2025Exercised options 8,636 shares at $0.18 of Edgewise Therapeutics, Inc.⁷
May 2, 2024Sold 3,152 shares at $18.91 of Edgewise Therapeutics, Inc.⁸
May 1, 2024Exercised options 10,417 shares of Edgewise Therapeutics, Inc.⁸
May 2, 2023Sold 3,203 shares at $8.90 of Edgewise Therapeutics, Inc.⁹
May 1, 2023Exercised options 10,416 shares of Edgewise Therapeutics, Inc.⁹

The numbers on this page point here. Each one links to the record it came from.